GlassScriptPhysician profile
Bradley B Williams
NPI 1437107836
$2,432.21
in general payments reported to CMS, 2019-2025
17 companies · $315 in 2025
The $315 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $296 · 2021: $312 · 2022: $178 · 2023: $185 · 2024: $807 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,289 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,288.55 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $352.65 | 2019-2025 | Clareon, Centurion, Rocklatan |
| Johnson & Johnson Surgical Vision, INC. | $345.93 | 2019-2024 | Tecnis Iol, Veritas Vision System |
| Abbvie INC. | $342.98 | 2024-2025 | |
| Horizon Therapeutics Plc | $312.04 | 2021 | |
| Bausch & Lomb Americas INC. | $181.62 | 2023-2024 | Miebo, Scoutpro Osmolarity System, Vyzulta |
| New World Medical,INC. | $119.05 | 2023-2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
| Zimmer Biomet Holdings, INC. | $116.09 | 2020 | |
| Mallinckrodt Hospital Products INC. | $112.64 | 2024 | Acthar |
| Sun Pharmaceutical Industries INC. | $111.48 | 2019-2020 | |
| Allergan, INC. | $106.44 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $99.97 | 2019 | |
| Dompe US, INC. | $89.99 | 2022-2025 | Oxervate |
| Mallinckrodt Enterprises LLC | $44.93 | 2019 | |
| Biotissue Holdings INC. | $44.66 | 2022-2023 | |
| Ocular Therapeutix, INC. | $18.22 | 2025 | Dextenza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $17.86 | 2023 | |
| Quidel Corporation | $15.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.